Drug Treatment of Obesity in Cardiovascular Disease

Author： Charakida Marietta   Finer Nicholas  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.2, 2012-04, pp. : 93-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease: Guide to Drug Selection

By Graham Jackson  

Drugs, Vol. 64, Iss. 14, 2004-01 ,pp. : 1533-1545

Adis International

Access to resources Recommend Favorite

Recent advancements in drug treatment of obesity

By Carter Rebeca   Mouralidarane Angelina   Ray Shuvra   Soeda Junpei   Oben Jude  

Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. : 456-460

Royal College Of Physicians

Access to resources Recommend Favorite

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5267-5280

Bentham Science Publishers

Access to resources Recommend Favorite

Why Does Obesity Increase the Risk for Cardiovascular Disease?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5678-5683

Bentham Science Publishers

Access to resources Recommend Favorite

Torcetrapib: promising in the treatment of cardiovascular disease

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite